Please use this identifier to cite or link to this item:
http://repository.tma.uz/xmlui/handle/1/7192
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Pulat M. Abilov1 , Bakhtiyor U. Iriskulov2 , Zukhra N. Boboeva3 | - |
dc.date.accessioned | 2023-04-25T13:00:00Z | - |
dc.date.available | 2023-04-25T13:00:00Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 2186-1326 | - |
dc.identifier.uri | http://repository.tma.uz/xmlui/handle/1/7192 | - |
dc.description.abstract | The current outbreak of coronavirus disease (COVID-19) is a global emergency as its rapid spread and high mortality rate have caused severe disruption. The number of people infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, is rapidly increasing worldwide. Patients with COVID-19 may develop pneumonia, severe symptoms of acute respiratory distress syndrome (ARDS) and multiple organ failure | en_US |
dc.relation.ispartofseries | №3; | - |
dc.subject | coronavirus infection, pathogenesis, acute respiratory syndrome, G. lucidum, Alkhadaya | en_US |
dc.title | PATHOPHYSIOLOGICAL SUBSTANTIATION OF THE USE OF A NEW DRUG BASED ON G. LUCIDUM AND ALKHADIA IN THE TREATMENT OF CORONAVIRUS INFECTION CAUSED BY SARS COV-2 | en_US |
dc.type | Article | en_US |
Appears in Collections: | Thesis, Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
0 Central As J of M 3,22-страницы-1,3,36-44,248-250.pdf | 3.44 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.